Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.91% |
| 2 | Technology | 4.35% |
| 3 | Healthcare | 4.25% |
| 4 | Industrials | 4.06% |
| 5 | Consumer Discretionary | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
PUT
Blackrock
BLK
$178B
| $119M | 0.05% |
252,000
+88,500
| +54% | +$43M |
|
352
CALL
iShares US Real Estate ETF
IYR
$4.49B
| $119M | 0.05% |
1,483,200
+697,100
| +89% | +$56.8M |
|
|
PX
353
CALL
DELISTED
Praxair Inc
PX
| $118M | 0.05% |
736,600
+185,000
| +34% | +$29.7M |
|
354
Nutrien
NTR
$31.8B
| $118M | 0.05% |
2,050,984
+1,946,532
| +1,864% | +$108M |
|
355
CALL
FedEx
FDX
$76.2B
| $118M | 0.05% |
488,000
-127,300
| -21% | -$30.8M |
|
|
COL
356
DELISTED
Rockwell Collins
COL
| $117M | 0.05% |
830,256
+826,884
| +24,522% | +$114M |
|
357
Alphabet (Google) Class C
GOOG
$4.19T
| $116M | 0.05% |
1,942,240
-1,138,900
| -37% | -$68.2M |
|
358
Cigna
CI
$72.1B
| $116M | 0.05% |
554,902
+434,393
| +360% | +$80.5M |
|
359
PUT
iShares Biotechnology ETF
IBB
$9.84B
| $115M | 0.05% |
946,000
+274,100
| +41% | +$32.3M |
|
360
lululemon athletica
LULU
$13.9B
| $115M | 0.05% |
709,866
+271,234
| +62% | +$37.2M |
|
361
Reinsurance Group of America
RGA
$16B
| $115M | 0.05% |
794,172
+275,628
| +53% | +$39M |
|
|
CELG
362
DELISTED
Celgene Corp
CELG
| $115M | 0.05% |
1,282,825
+142,848
| +13% | +$12.6M |
|
363
CALL
Lockheed Martin
LMT
$138B
| $114M | 0.05% |
329,700
-31,800
| -9% | -$10.3M |
|
364
PUT
Shopify
SHOP
$194B
| $114M | 0.05% |
6,930,000
-314,000
| -4% | -$4.78M |
|
365
PUT
Northrop Grumman
NOC
$81.4B
| $114M | 0.05% |
359,000
+126,500
| +54% | +$38.6M |
|
366
PUT
Target
TGT
$69B
| $114M | 0.05% |
1,287,200
+116,700
| +10% | +$9.71M |
|
367
CALL
Qualcomm
QCOM
$171B
| $113M | 0.05% |
1,572,300
+322,800
| +26% | +$21.2M |
|
368
PVH
PVH
$3.77B
| $113M | 0.05% |
779,572
+360,169
| +86% | +$53.3M |
|
369
PUT
Verizon
VZ
$195B
| $113M | 0.05% |
2,107,800
+578,300
| +38% | +$30.6M |
|
370
Berkshire Hathaway Class B
BRK.B
$1.09T
| $112M | 0.05% |
521,779
+290,761
| +126% | +$59.7M |
|
371
Ameriprise Financial
AMP
$49.4B
| $111M | 0.05% |
755,024
-441,347
| -37% | -$63.2M |
|
372
Incyte
INCY
$24.4B
| $111M | 0.05% |
1,613,707
-273,493
| -14% | -$18.8M |
|
373
PUT
Lam Research
LRCX
$407B
| $111M | 0.05% |
7,340,000
-2,248,000
| -23% | -$38.4M |
|
374
CALL
Biogen
BIIB
$30.2B
| $111M | 0.05% |
314,900
+102,300
| +48% | +$35.2M |
|
|
B
375
Barrick Mining
B
$67.7B
| $111M | 0.05% |
10,038,704
+6,110,345
| +156% | +$68M |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.